Published in J Virol on May 01, 1991
Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res (1991) 2.92
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3' untranslated regions and role of ribosome translocation. Mol Cell Biol (1994) 1.76
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol (2000) 1.62
Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J Virol (1995) 1.59
Synergistic action of interleukin-6 and glucocorticoids is mediated by the interleukin-6 response element of the rat alpha 2 macroglobulin gene. Mol Cell Biol (1992) 1.46
Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol (2010) 1.30
Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein. J Virol (1993) 1.28
Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc Natl Acad Sci U S A (1992) 1.17
An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J Virol (2003) 1.13
A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer. J Virol (1999) 1.00
Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter. J Virol (1993) 0.96
Efficient transcription from the rice tungro bacilliform virus promoter requires elements downstream of the transcription start site. J Virol (1996) 0.91
Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter. J Virol (2004) 0.90
Requirements for enhanced transgene expression by untranslated sequences from the human cytomegalovirus immediate-early gene. Mol Med (1998) 0.88
IE2 protein is insufficient for transcriptional repression of the human cytomegalovirus US3 promoter. J Virol (1997) 0.86
Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter. J Virol (2000) 0.85
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell (1985) 11.28
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (1988) 10.15
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell (1989) 6.11
Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J Virol (1985) 5.47
Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 5.04
Translational and transcriptional control elements in the untranslated leader of the heat-shock gene hsp22. Cell (1986) 5.00
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J (1989) 4.24
Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J (1987) 4.14
Separation and partial characterization of three functional steps in transcription initiation by human RNA polymerase II. J Biol Chem (1985) 3.89
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus. J Virol (1987) 3.68
NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J (1989) 3.58
HIV-1 Tat protein trans-activates transcription in vitro. Cell (1990) 3.57
Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev (1988) 3.51
Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell (1990) 3.27
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell (1990) 2.82
HIV TAR: an RNA enhancer? Cell (1989) 2.74
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J (1986) 2.62
Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature (1990) 2.47
Equipotent mouse ribosomal protein promoters have a similar architecture that includes internal sequence elements. Genes Dev (1989) 2.42
In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev (1989) 2.36
The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol (1989) 2.32
Transcriptional but not translational regulation of HIV-1 by the tat gene product. Nature (1988) 2.15
Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Virol (1990) 2.06
Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol Cell Biol (1986) 2.05
Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression. Science (1986) 1.95
HIV-1 TAT "activates" presynthesized RNA in the nucleus. Cell (1989) 1.89
Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1987) 1.88
Downstream sequences affect transcription initiation from the adenovirus major late promoter. Mol Cell Biol (1986) 1.82
The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO J (1986) 1.80
Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate-early gene. J Virol (1988) 1.78
Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol (1990) 1.76
Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55
Sequences downstream of the transcription initiation site modulate the activity of the murine dihydrofolate reductase promoter. Mol Cell Biol (1990) 1.52
Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol Cell Biol (1988) 1.47
The palindromic series I repeats in the simian cytomegalovirus major immediate-early promoter behave as both strong basal enhancers and cyclic AMP response elements. J Virol (1990) 1.45
Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res (1989) 1.40
High-level transcription from the adenovirus major late promoter requires downstream binding sites for late-phase-specific factors. J Virol (1990) 1.34
Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. J Biol Chem (1989) 1.26
A downstream-element-binding factor facilitates assembly of a functional preinitiation complex at the simian virus 40 major late promoter. Mol Cell Biol (1990) 1.21
Cell-specific expression of the human gastrin gene: evidence for a control element located downstream of the TATA box. Mol Cell Biol (1987) 1.08
Muscle-specific activity of the skeletal troponin I promoter requires interaction between upstream regulatory sequences and elements contained within the first transcribed exon. Mol Cell Biol (1990) 1.07
Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP. J Virol (1990) 1.05
Interactions between cellular regulatory proteins and a unique sequence region in the human cytomegalovirus major immediate-early promoter. Virology (1990) 0.95
Cell-specific activity of the human immunodeficiency virus enhancer repeat in vitro. AIDS Res Hum Retroviruses (1988) 0.92
A rapid and selective method for generating deletions, insertions and clustered point mutations. Biotechniques (1990) 0.79
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol (1997) 4.17
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell (1997) 3.99
Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol (1989) 3.98
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69
BEACHES: an observational system for assessing children's eating and physical activity behaviors and associated events. J Appl Behav Anal (1991) 3.61
Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc (1993) 3.57
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol (1999) 3.02
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol (1987) 2.97
Correlates of physical activity at home in Mexican-American and Anglo-American preschool children. Health Psychol (1993) 2.74
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med (1990) 2.45
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol (1999) 2.07
Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol Cell Biol (1986) 2.05
Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00
Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood (1996) 1.98
HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94
The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol (2000) 1.92
Do pathogens accelerate atherosclerosis? J Nutr (2001) 1.91
Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis (1987) 1.91
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol (1982) 1.88
Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection. Cancer Res (1977) 1.87
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology (1993) 1.81
Television's influence on children's diet and physical activity. J Dev Behav Pediatr (1989) 1.77
Radiographic findings of the National Cooperative Crohn's Disease Study. Gastroenterology (1979) 1.77
Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A (1993) 1.73
Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex. J Virol (1997) 1.73
Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis (1998) 1.72
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65
Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest (1997) 1.62
A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J Virol (1991) 1.62
Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J Virol (1995) 1.59
Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol (1988) 1.57
Energy and macronutrient intakes of elite figure skaters. J Am Diet Assoc (2001) 1.56
Human cytomegalovirus persistently infects aortic endothelial cells. J Virol (1998) 1.55
Aerobic and anaerobic swimming performance of individual Atlantic cod. J Exp Biol (2000) 1.55
Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol (1995) 1.52
Thermally induced asthma and airway drying. Am J Respir Crit Care Med (1999) 1.52
Gossypiboma--the problem of the retained surgical sponge. Radiology (1978) 1.52
An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology (1992) 1.51
Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol (1988) 1.49
THE MILLER-ABBOTT TUBE AS AN ADJUNCT TO SURGERY OF SMALL INTESTINAL OBSTRUCTIONS. Ann Surg (1940) 1.49
Effects of dichlorodiphenyltrichloroethane (DDT) analogs and polychlorinated biphenyl (PCB) mixtures on 17beta-(3H)estradiol binding to rat uterine receptor. Biochem Pharmacol (1974) 1.48
Spatial analysis of the distribution of Ixodes dammini (Acari: Ixodidae) on white-tailed deer in Ogle County, Illinois. J Med Entomol (1992) 1.47
T cell recognition of HIV synthetic peptides in a natural infection. J Immunol (1989) 1.47
HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet (1990) 1.45
B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. J Virol (1988) 1.42
Effect of spectral shaping and content on loudness discomfort. J Am Acad Audiol (2001) 1.42
Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol (1988) 1.41
Individual variation and repeatability in aerobic and anaerobic swimming performance of European sea bass, Dicentrarchus labrax. J Exp Biol (2010) 1.39
T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol (1990) 1.38
The Caltrac accelerometer as a physical activity monitor for school-age children. Med Sci Sports Exerc (1990) 1.38
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol (1996) 1.37
Structure of the transforming region of human cytomegalovirus AD169. J Virol (1984) 1.35
Small fragments of herpesvirus DNA with transforming activity contain insertion sequence-like structures. Proc Natl Acad Sci U S A (1984) 1.34
Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) (2005) 1.30
Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation state of Ser900. J Virol (1998) 1.29
Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein. J Virol (1993) 1.28
Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res (1994) 1.27
Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol (2008) 1.27
Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol (1996) 1.27
A protein-based therapeutic for human cytomegalovirus infection. Proc Natl Acad Sci U S A (2000) 1.23
Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res (1975) 1.23
Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol (1999) 1.23
European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis (1996) 1.23
24,25-Epoxysterol metabolism in cultured mammalian cells and repression of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem (1986) 1.21
Anglo- and Mexican-American preschoolers at home and at recess: activity patterns and environmental influences. J Dev Behav Pediatr (1992) 1.18
Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy. Acta Neuropathol (1988) 1.16
Reliability of interviewers using the Seven-Day Physical Activity Recall. Res Q Exerc Sport (1990) 1.14
24(S),25-Epoxycholesterol. Evidence consistent with a role in the regulation of hepatic cholesterogenesis. J Biol Chem (1985) 1.14
Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide. J Biol Chem (1981) 1.14
Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology (1990) 1.13
Infant-feeding practices and adiposity in 4-y-old Anglo- and Mexican-Americans. Am J Clin Nutr (1992) 1.13
Increased purine nucleotides in adenosine deaminase-deficient lymphocytes. J Pediatr (1977) 1.13
In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents. Antimicrob Agents Chemother (1993) 1.12
Peak shift as a function of multiple schedules of reinforcement. J Exp Anal Behav (1974) 1.12
Cytomegalovirus persistence in macrophages and endothelial cells. Scand J Infect Dis Suppl (1995) 1.09
Infection rate of Ixodes ricinus ticks with Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto in Slovenia. Eur J Clin Microbiol Infect Dis (1995) 1.08
The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant (2007) 1.05
Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J Virol (1995) 1.05
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency. J Clin Invest (1976) 1.03
Growth of human cytomegalovirus in primary macrophages. Methods (1998) 1.03